PharmacyGPT: The AI Pharmacist

• URL: http://arxiv.org/abs/2307.10432v3
• Date: Thu, 03 Oct 2024 17:55:29 GMT
• Title: PharmacyGPT: The AI Pharmacist
• Authors: Zhengliang Liu, Zihao Wu, Mengxuan Hu, Bokai Zhao, Lin Zhao, Tianyi Zhang, Haixing Dai, Xianyan Chen, Ye Shen, Sheng Li, Quanzheng Li, Xiang Li, Brian Murray, Tianming Liu, Andrea Sikora,
• Abstract summary: We introduce PharmacyGPT, a framework to assess the capabilities of large language models (LLMs) in emulating the role of clinical pharmacists. We conduct our investigation using real data acquired from the intensive care unit (ICU) at the University of North Carolina Chapel Hill (UNC) Hospital.
• Score: 38.247456673883114
• License:
• Abstract: In this study, we introduce PharmacyGPT, a novel framework to assess the capabilities of large language models (LLMs) such as ChatGPT and GPT-4 in emulating the role of clinical pharmacists. Our methodology encompasses the utilization of LLMs to generate comprehensible patient clusters, formulate medication plans, and forecast patient outcomes. We conduct our investigation using real data acquired from the intensive care unit (ICU) at the University of North Carolina Chapel Hill (UNC) Hospital. Our analysis offers valuable insights into the potential applications and limitations of LLMs in the field of clinical pharmacy, with implications for both patient care and the development of future AI-driven healthcare solutions. By evaluating the performance of PharmacyGPT, we aim to contribute to the ongoing discourse surrounding the integration of artificial intelligence in healthcare settings, ultimately promoting the responsible and efficacious use of such technologies.

Related papers

• PALLM: Evaluating and Enhancing PALLiative Care Conversations with Large Language Models [10.258261180305439]
  Large language models (LLMs) offer a new approach to assessing complex communication metrics. LLMs offer the potential to advance the field through integration into passive sensing and just-in-time intervention systems. This study explores LLMs as evaluators of palliative care communication quality, leveraging their linguistic, in-context learning, and reasoning capabilities.
  arXiv  Detail & Related papers  (2024-09-23T16:39:12Z)
• Large Language Models in Drug Discovery and Development: From Disease Mechanisms to Clinical Trials [49.19897427783105]
  The integration of Large Language Models (LLMs) into the drug discovery and development field marks a significant paradigm shift. We investigate how these advanced computational models can uncover target-disease linkage, interpret complex biomedical data, enhance drug molecule design, predict drug efficacy and safety profiles, and facilitate clinical trial processes.
  arXiv  Detail & Related papers  (2024-09-06T02:03:38Z)
• Dr-LLaVA: Visual Instruction Tuning with Symbolic Clinical Grounding [53.629132242389716]
  Vision-Language Models (VLM) can support clinicians by analyzing medical images and engaging in natural language interactions. VLMs often exhibit "hallucinogenic" behavior, generating textual outputs not grounded in contextual multimodal information. We propose a new alignment algorithm that uses symbolic representations of clinical reasoning to ground VLMs in medical knowledge.
  arXiv  Detail & Related papers  (2024-05-29T23:19:28Z)
• Automatic Interactive Evaluation for Large Language Models with State Aware Patient Simulator [21.60103376506254]
  Large Language Models (LLMs) have demonstrated remarkable proficiency in human interactions. This paper introduces the Automated Interactive Evaluation (AIE) framework and the State-Aware Patient Simulator (SAPS) AIE and SAPS provide a dynamic, realistic platform for assessing LLMs through multi-turn doctor-patient simulations.
  arXiv  Detail & Related papers  (2024-03-13T13:04:58Z)
• AI Hospital: Benchmarking Large Language Models in a Multi-agent Medical Interaction Simulator [69.51568871044454]
  We introduce textbfAI Hospital, a framework simulating dynamic medical interactions between emphDoctor as player and NPCs. This setup allows for realistic assessments of LLMs in clinical scenarios. We develop the Multi-View Medical Evaluation benchmark, utilizing high-quality Chinese medical records and NPCs.
  arXiv  Detail & Related papers  (2024-02-15T06:46:48Z)
• Large Language Model Distilling Medication Recommendation Model [61.89754499292561]
  We harness the powerful semantic comprehension and input-agnostic characteristics of Large Language Models (LLMs) Our research aims to transform existing medication recommendation methodologies using LLMs. To mitigate this, we have developed a feature-level knowledge distillation technique, which transfers the LLM's proficiency to a more compact model.
  arXiv  Detail & Related papers  (2024-02-05T08:25:22Z)
• ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management [3.843569766201585]
  The aim of ABiMed is to design an innovative clinical decision support system for medication reviews and polypharmacy management. ABiMed associates several approaches: guidelines implementation, but the automatic extraction of patient data from the GP's electronic health record and its transfer to the pharmacist, and the visual presentation of contextualized drug knowledge using visual analytics.
  arXiv  Detail & Related papers  (2023-12-13T11:06:45Z)
• Large Language Models Illuminate a Progressive Pathway to Artificial Healthcare Assistant: A Review [16.008511195589925]
  Large language models (LLMs) have shown promising capabilities in mimicking human-level language comprehension and reasoning. This paper provides a comprehensive review on the applications and implications of LLMs in medicine.
  arXiv  Detail & Related papers  (2023-11-03T13:51:36Z)
• SynerGPT: In-Context Learning for Personalized Drug Synergy Prediction and Drug Design [64.69434941796904]
  We propose a novel setting and models for in-context drug synergy learning. We are given a small "personalized dataset" of 10-20 drug synergy relationships in the context of specific cancer cell targets. Our goal is to predict additional drug synergy relationships in that context.
  arXiv  Detail & Related papers  (2023-06-19T17:03:46Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.